Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Recall of Cannabis for Medical Purposes - Aphria

Starting date:
March 8, 2017
Type of communication:
Drug Recall
Hazard classification:
Type III
Source of recall:
Health Canada
Labelling and Packaging
General Public
Identification number:


On March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. The affected lot number can be found below.


On March 8, 2017, Aphria initiated a voluntary Type III recall for one lot of product due to the mislabelling of the delta-9-tetrahydrocannabidiol (THC) content of the products. The THC content identified on the label was higher than the concentration present in the products. The products were mislabelled as containing 22.3% THC instead of 21.1% THC.

A Type III recall refers to a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number 1-844-427-4742.

Affected products

Dried marijuana

Not Applicable
Dosage form

Not Applicable


22.3% THC

Lot or serial number

The following lots are classified under the Type III recall initiated on March 8, 2017.


Recalling Firm
Tel: 1-844-427-4742
Marketing Authorization Holder
Not Applicable

Media enquiries

Santé Canada
(613) 957-2983